Medindia

X

Research Suggests Nonsense Suppression Drug Restores Function in a Mouse Model of Aniridia

by Kathy Jones on  December 23, 2013 at 8:06 PM Drug News   - G J E 4
Congenital aniridia is a condition that causes improper development of eye structures as well as abnormalities in the brain and pancreas.
 Research Suggests Nonsense Suppression Drug Restores Function in a Mouse Model of Aniridia
Research Suggests Nonsense Suppression Drug Restores Function in a Mouse Model of Aniridia
Advertisement

A variety of nonsense mutations in the PAX6 gene are linked with aniridia; however, despite understanding the genetic basis of the disease, few treatment and prevention strategies are available. In this issue of the Journal of Clinical Investigation, Cheryl Gregory-Evans and colleagues at the University of British Columbia evaluated a small molecule nonsense suppression strategy for relief of aniridia-associated defects in a mouse model of the disease. The authors developed a formulation of the nonsense suppression drug ataluren that could be given topically to postnatal aniridia mice. Administration of their ataluren-based formulation inhibited disease progression, reversed eye deformations, and restored eye function in aniridia mice. In an accompanying commentary, José-Alain Sahel and Katia Marazova of the Institut de la Vision suggest that ataluren administration should be further explored as a therapeutic option for treatment of congenital eye defects associated with nonsense mutations.

Advertisement


Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All